Protagonist Therapeutics, Inc. (PTGX) Profit Margin
Protagonist Therapeutics, Inc. (PTGX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | -184.20% |
| 2018-12-31 | -125.87% |
| 2019-12-31 | -120604.69% |
| 2020-12-31 | -231.07% |
| 2021-12-31 | -458.94% |
| 2022-12-31 | -479.26% |
| 2023-12-31 | -131.59% |
| 2024-12-31 | 63.34% |
| 2025-12-31 | -282.83% |
How PTGX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NVST | Envista Holdings Corporation | 1.73% |
| ICUI | ICU Medical Inc. | 0.03% |
| AMN | AMN Healthcare Services Inc | -3.51% |
| ETON | Eton Pharmaceuticals Inc. | -5.75% |
| VTRS | Viatris Inc. | -24.58% |
These are five companies in the same sector as PTGX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("PTGX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PTGX | $155.10 | +0.00% | 0.44M |
| 3 | ||||
| 4 | ||||
| 5 |